This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,717.82, is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract is a firm fixed-price, delivery order type with an ultimate completion date of January 2, 2025. The contract is not designated as a set-aside and was awarded without any specific set-aside requirements. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 4/1/25, 10:51 AM